Literature DB >> 9452976

Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles.

H Sugao1, S Yamazaki, H Shiozawa, K Yano.   

Abstract

Indeloxazine hydrochloride (IDX), a cerebral activator, has a bitter astringent taste. To prepare powders of IDX without this bitter taste, microparticles (median diameter, 130 microns) of IDX were coated with a mixture comprising hydrogenated oil and surfactants in a fluidized bed using the side-spray method. Drug release from the resulting coated particles was significantly delayed. Dissolution rate was remarkably enhanced, however, by heat-treating the coated particles at a temperature above the melting point of the surfactant in the coated layer. The results of differential scanning calorimetry measurements show that part of the surfactant in the coated layer exists separately. Further, surface changes in the coated layer before and after heat treatment showed that this enhancement of dissolution rate was due to rediffusion of the surfactant in the coated layer followed by melting of the surfactant. This effect allows the design of powders of IDX which release the drug quickly and with bioequivalence to the commercial IDX 20 mg tablets while sufficiently suppressing the bitter taste.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452976     DOI: 10.1021/js970104g

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures.

Authors:  Yangjie Wei; Michael P Nedley; Sarit B Bhaduri; Xavier Bredzinski; Sai H S Boddu
Journal:  AAPS PharmSciTech       Date:  2014-11-01       Impact factor: 3.246

2.  Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.

Authors:  Dionysios Dennis Douroumis; Andreas Gryczke; Silke Schminke
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

3.  Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.

Authors:  Xuelian Hu; Yingbo Li; Engjuan Zhang; Xianzhu Wang; Mao Xing; Qian Wang; Jian Lei; Hua Huang
Journal:  AAPS PharmSciTech       Date:  2012-11-22       Impact factor: 3.246

4.  Improved bioavailability through floating microspheres of lovastatin.

Authors:  S Kumar; K Nagpal; Sk Singh; Dn Mishra
Journal:  Daru       Date:  2011       Impact factor: 3.117

5.  Formulation development and evaluation of metformin chewing gum with bitter taste masking.

Authors:  Sayed Abolfazl Mostafavi; Jaleh Varshosaz; Saber Arabian
Journal:  Adv Biomed Res       Date:  2014-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.